Literature DB >> 21291883

Modulation of benzodiazepine receptor, adrenoceptor and muscarinic receptor by diazepam in rat parotid gland.

Kazunori Ouchi1, Hisako Yamagishi-Wang, Kohei Sawaki, Masahito Watanabe, Toshihiko Kawano, Mitsuru Kawaguchi.   

Abstract

This study investigated the influence of diazepam on the binding characteristics of adrenoceptor, muscarinic and benzodiazepine receptors in rat parotid gland membrane using a radioligand binding assay. At a concentration of >10(-6)M, diazepam competed with [(3)H]dihydroalprenolol for β-adrenoceptor, but not [(3)H]prazosin for α-adrenoceptor or [(3)H]quinuclidinyl benzilate for muscarinic receptor. Continuous administration of diazepam at doses of 0.4mg/kg/day, i.p. for 7days in rat significantly decreased pilocarpine (4.0mg/kg, i.p.)-induced parotid salivary flow. Diazepam also produced a significant increase in the dissociation constant (Kd) value for [(3)H]dihydroalprenolol binding, but no change in the maximal binding capacity (Bmax) value, and a decrease in the Kd value for [(3)H]diazepam binding to benzodiazepine receptors, but no change in the Kd or Bmax values for [(3)H]prazosin or [(3)H]quinuclidinyl benzilate binding. These results suggest that continuous administration of diazepam modifies affinity for β-adrenoceptor and benzodiazepine receptor binding sites in parotid gland membrane and that changes in these binding sites may be closely related to diazepam-induced suppression of salivary secretion.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21291883     DOI: 10.1016/j.ejphar.2011.01.029

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  1 in total

1.  Effects of Benzodiazepines on Acinar and Myoepithelial Cells.

Authors:  Tatiana M F Mattioli; Luciana R A Alanis; Silvana da Silva Sapelli; Antonio A S de Lima; Lucia de Noronha; Edvaldo A R Rosa; Yusuf S Althobaiti; Atiah H Almalki; Youssef Sari; Sergio A Ignacio; Aline C B R Johann; Ana M T Gregio
Journal:  Front Pharmacol       Date:  2016-06-24       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.